157 related articles for article (PubMed ID: 1012983)
21. Nicotine hypothermia and brain nicotine and catecholamine levels in the mouse.
Mansner R; Alhava E; Klinge E
Med Biol; 1974 Dec; 52(6):390-8. PubMed ID: 4444360
[No Abstract] [Full Text] [Related]
22. Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after alpha-methyl-p-tyrosine; time- and dose-response relationships.
Widerlöv E; Lewander T
Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):111-23. PubMed ID: 703854
[TBL] [Abstract][Full Text] [Related]
23. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
Dolphin A; Jenner P; Marsden CD
Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534
[No Abstract] [Full Text] [Related]
24. Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity.
Dolphin A; Jenner P; Marsden CD
Pharmacol Biochem Behav; 1976 Oct; 5(4):431-9. PubMed ID: 1005491
[TBL] [Abstract][Full Text] [Related]
25. The effect of intraventricular dopamine on the spontaneous locomotor activity of rats pretreated with nialamide, reserpine, or alpha-methyl-p-tyrosine.
Malec D; Kleinrok Z
Pol J Pharmacol Pharm; 1973; 25(4):357-66. PubMed ID: 4774244
[No Abstract] [Full Text] [Related]
26. The effect of dopamine-beta-hydroxylase inhibitors, dimethylphenylthiourea and fusaric acid, on locomotor and exploratory activity, body temperature, and regional distribution of biogenic amines in the rat brain.
Vetulani J; Reichenberg K; wiszniowska G; Marchaj J
Pol J Pharmacol Pharm; 1973; 25(6):559-72. PubMed ID: 4792476
[No Abstract] [Full Text] [Related]
27. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
Kokkinidis L; Irwin J; Anisman H
Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
[No Abstract] [Full Text] [Related]
28. Cerebral dopamine and noradrenaline turnover and effects of morphine test dose in rats withdrawn from 20 days' morphine treatment.
Attila LM; Ahtee L
Med Biol; 1983; 61(5):249-257. PubMed ID: 6686987
[TBL] [Abstract][Full Text] [Related]
29. [The brain catecholamine systems in the regulation of dominance].
Serova LI; Naumenko EV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(3):490-6. PubMed ID: 1975967
[TBL] [Abstract][Full Text] [Related]
30. Brain ascorbic acid and block of the catecholamine synthesis induced by alpha-methyl-tyrosine.
Loscalzo B; Agrusta A; Agrusta M; Crisci A; Genovese L; Marino M
Boll Soc Ital Biol Sper; 1984 Sep; 60(9):1735-8. PubMed ID: 6151844
[TBL] [Abstract][Full Text] [Related]
31. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
Rech RH; Carr LA; Moore KE
J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
[No Abstract] [Full Text] [Related]
32. Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines.
Brodie BB; Costa E; Dlabac A; Neff NH; Smookler HH
J Pharmacol Exp Ther; 1966 Dec; 154(3):493-8. PubMed ID: 5928249
[No Abstract] [Full Text] [Related]
33. Environmental light conditions alter gene expression of rat catecholamine biosynthetic enzymes and Neuropeptide Y: differential effect in superior cervical ganglia and adrenal gland.
Gallara RV; Bellavia SL; Serova LL; Sabban EL
Brain Res Mol Brain Res; 2004 May; 124(2):152-8. PubMed ID: 15135223
[TBL] [Abstract][Full Text] [Related]
34. Some catecholamine inhibitors do not cause accumulation of nuclear estrogen receptors in rat hypothalamus and anterior pituitary gland.
Blaustein JD; Brown TJ; McElroy JF
Neuroendocrinology; 1986; 43(2):143-9. PubMed ID: 2873523
[TBL] [Abstract][Full Text] [Related]
35. Morphine lethality in rats: effects of inhibitors of brain catecholamine synthesis and methylation.
Davis WM; Khalsa JH
Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):867-72. PubMed ID: 4148579
[No Abstract] [Full Text] [Related]
36. Thyrotropin-releasing hormone in the pancreas and brain of the rat is regulated by central noradrenergic and dopaminergic pathways.
Engler D; Chad D; Jackson IM
J Clin Invest; 1982 Jun; 69(6):1310-20. PubMed ID: 6806317
[TBL] [Abstract][Full Text] [Related]
37. Suppression of ethanol intake following administration of dopamine-beta-hydroxylase inhibitors in rats.
Amit Z; Levitan DE; Lindros KO
Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):114-9. PubMed ID: 999391
[TBL] [Abstract][Full Text] [Related]
38. Involvement of catecholaminergic mechanisms in the photoperiodically induced rise in serum luteinizing hormone of Japanese quail (Coturnix coturnix japonica).
El Halawani ME; Burke WH; Ogren LA
Gen Comp Endocrinol; 1980 May; 41(1):14-21. PubMed ID: 7390138
[No Abstract] [Full Text] [Related]
39. Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylase.
Dolphin A; Jenner P; Marsden CD
Eur J Pharmacol; 1976 Jan; 35(1):135-44. PubMed ID: 1253815
[TBL] [Abstract][Full Text] [Related]
40. Proceedings: Biochemical evidence for the involvement of noradrenaline in motor activity produced by L-DOPA in rodents.
Dolphin A; Jenner P; Marsden CD
Br J Pharmacol; 1975 Oct; 55(2):292P. PubMed ID: 1201420
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
